DE69112573D1 - Immunstimulierendes arzneimittel, das polare glycopeptidolipide von mycobakterium-chelonae enthält. - Google Patents

Immunstimulierendes arzneimittel, das polare glycopeptidolipide von mycobakterium-chelonae enthält.

Info

Publication number
DE69112573D1
DE69112573D1 DE69112573T DE69112573T DE69112573D1 DE 69112573 D1 DE69112573 D1 DE 69112573D1 DE 69112573 T DE69112573 T DE 69112573T DE 69112573 T DE69112573 T DE 69112573T DE 69112573 D1 DE69112573 D1 DE 69112573D1
Authority
DE
Germany
Prior art keywords
pct
chelonae
polyglycopeptidolipid
mycobakterium
immuntimulating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69112573T
Other languages
English (en)
Other versions
DE69112573T2 (de
Inventor
Tsehay Neway
Charles Pilet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE69112573D1 publication Critical patent/DE69112573D1/de
Application granted granted Critical
Publication of DE69112573T2 publication Critical patent/DE69112573T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/863—Mycobacterium
DE69112573T 1990-06-06 1991-06-06 Immunstimulierendes arzneimittel, das polare glycopeptidolipide von mycobakterium-chelonae enthält. Expired - Fee Related DE69112573T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9006997A FR2662942B1 (fr) 1990-06-06 1990-06-06 Medicament immunostimulant a base de glycopeptidolipides polaires de mycobacterium chelonae.
PCT/FR1991/000449 WO1991018617A1 (fr) 1990-06-06 1991-06-06 Medicament immunostimulant a base de glycopeptidolipides polaires de mycobacterium chelonae

Publications (2)

Publication Number Publication Date
DE69112573D1 true DE69112573D1 (de) 1995-10-05
DE69112573T2 DE69112573T2 (de) 1996-04-25

Family

ID=9397303

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69112573T Expired - Fee Related DE69112573T2 (de) 1990-06-06 1991-06-06 Immunstimulierendes arzneimittel, das polare glycopeptidolipide von mycobakterium-chelonae enthält.

Country Status (12)

Country Link
US (1) US5336666A (de)
EP (1) EP0485577B1 (de)
JP (1) JP2709979B2 (de)
AT (1) ATE127021T1 (de)
AU (1) AU655425B2 (de)
CA (1) CA2063721C (de)
DE (1) DE69112573T2 (de)
DK (1) DK0485577T3 (de)
ES (1) ES2080320T3 (de)
FR (1) FR2662942B1 (de)
GR (1) GR3018244T3 (de)
WO (1) WO1991018617A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0681479T3 (da) * 1993-01-29 1999-11-08 Vetrepharm Inc Immunterapeutisk præparat
EP0714305B1 (de) * 1993-08-27 2001-12-19 Vetrepharm, Inc. Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung
US6139844A (en) * 1997-04-02 2000-10-31 Bioniche, Inc. Method for treating or eliminating a parasitic disease
US7135191B2 (en) * 1997-09-04 2006-11-14 Zsolt Istvan Hertelendy Urogenital or anorectal transmucosal vaccine delivery system
GB9822619D0 (en) * 1998-10-19 1998-12-09 Porter William L Immune response stimulation
US6592869B2 (en) * 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
PL364983A1 (en) * 1999-08-24 2004-12-27 Teva Pharmaceutical Industries, Ltd. A vaccine composition and method of using the same
WO2003049751A1 (en) * 2001-12-10 2003-06-19 Bakulesh Mafatlal Khamar The process of manufacturing a pharmaceutical composition useful for management of cancer
TWI745278B (zh) 2014-10-10 2021-11-11 以色列商艾畢克生物實驗有限公司 發泡性降低之疫苗組合物

Also Published As

Publication number Publication date
DE69112573T2 (de) 1996-04-25
GR3018244T3 (en) 1996-02-29
FR2662942A1 (fr) 1991-12-13
CA2063721C (fr) 1998-10-27
EP0485577B1 (de) 1995-08-30
ATE127021T1 (de) 1995-09-15
DK0485577T3 (da) 1996-01-15
JPH05500817A (ja) 1993-02-18
WO1991018617A1 (fr) 1991-12-12
JP2709979B2 (ja) 1998-02-04
CA2063721A1 (fr) 1991-12-07
ES2080320T3 (es) 1996-02-01
AU8090591A (en) 1991-12-31
AU655425B2 (en) 1994-12-22
EP0485577A1 (de) 1992-05-20
US5336666A (en) 1994-08-09
FR2662942B1 (fr) 1992-09-18

Similar Documents

Publication Publication Date Title
NO952321D0 (no) Polypeptid, samt anti-HIV-preparat fremstilt fra dette
SE8300736D0 (sv) Novel pharmacologically active compounds
DK0597088T3 (da) Nye imidazolderivater, deres fremstilling og terapeutiske anvendelser
PT83872A (de) Arzneimittel
MY101784A (en) Novel pharmacological compounds
ES2177642T3 (es) Uso de ciertos derivados de acido metanobisfosfonico para prevenir el desprendimiento y la migracion de protesis.
FR2681784B1 (fr) Composition dermatologique et/ou cosmetologique contenant des retinouides et utilisation de nouveaux retinouides.
KR870700599A (ko) 카르복실산유도체, 그의 제조방법, 이화합물을 함유한 약제조성물 및 그의 용도
DE69217554T2 (de) Ebastin oder ebastin-analoga enthaltende arzneimittel
DE69112573T2 (de) Immunstimulierendes arzneimittel, das polare glycopeptidolipide von mycobakterium-chelonae enthält.
DE69311541D1 (de) Kosmetische oder pharmazeutische zusammensetzungen zur topischen anwendung die deacylierten glycerophospholipide enthalten
IL88971A0 (en) Disubstituted pyridines,their preparation and pharmaceutical compositions containing them
ES2153842T3 (es) Derivados de 3-oxo-pirido(1,2-a-)bencimidazol-4-carboxilo y de 4-oxo-azepino(1,2-a)bencimidazol-5-carboxilo utiles en el tratamiento de enfermedades del sistema nervioso central.
ES2060293T3 (es) Nueva sustancia antiulcerosa.
KR950702185A (ko) 약제약적 피리딘 화합물(pharmaceutical pyridine comdounds)본 내용은 요부공개 건이므로 전문 내용을 수록하지 않았음
BG102404A (en) The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
PT100891A (pt) Per-hidro-1h-pirido {1,2-a} pirazinas 2-substituidas neurolepticas
EP0330924A3 (de) Verwendung von 1,4-Dihydropyridin-Derivaten in der Behandlung von Alkoholsucht
DE69323191T2 (de) Wasserlösliche retinoide
ATE144986T1 (de) Aminoacylderivate von gem- diphosphonsauren,verfahren zu deren herstellung und pharmazeutische zubereitungen,die sie enthalten
IE781545L (en) Benzimidazole-2-derivatives.
SE8704049D0 (sv) Novel pharmacological compounds
MY106292A (en) (alpha)-adrenergic receptor antagonists.
JO1519B1 (en) New compounds (new benzimidazole derivatives are effective as ulcers)
ATE221068T1 (de) Anellierte beta-carboline

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee